GlassScriptPhysician profile
Angela Williams
NPI 1124511316
$654.49
in general payments reported to CMS, 2019-2025
12 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2024: $222 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $149.20 | 2021 | |
| Antares Pharma, INC. | $119.06 | 2024-2025 | Xyosted |
| Shield Therapeutics INC | $75.98 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $64.77 | 2024-2025 | |
| Novo Nordisk INC | $62.89 | 2024 | Wegovy |
| Lilly USA, LLC | $46.44 | 2025 | Zepbound |
| Millicent US INC | $30.61 | 2025 | Femlyv, Intrarosa |
| Astellas Pharma US INC | $25.08 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $24.52 | 2024 | Aptima |
| Exact Sciences Corporation | $20.34 | 2024 | Cologuard Collection Kit |
| Verity Pharmaceuticals INC. | $18.77 | 2024 | Tlando |
| Ibsa Pharma INC. | $16.83 | 2025 | Tirosint, Licart, Flector |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.